NUTEX Plc.
- Introduction
- Trading data
- Financials
- Shareholders, management
- Publications
- Product features
| Full Name | NUTEX Investments Public Limited Company | ||||||
| Short name | NUTEX Plc. | ||||||
| Sector | Diversified Financials | ||||||
| Contact |
HU-1163 Budapest, Cziráki utca 24-32. A. ép. II. em. 141.
Phone: -
Fax: -
Web: www.nutex.hu
|
||||||
| Investor Relations | |||||||
| Auditor | CMT Consulting Kft. (Auditor: Freiszberger Zsuzsanna) | ||||||
| Business activity | Its main activity is the research, development, manufacturing and distribution of medicinal products containing the active ingredient Humifulvát. In 1991, the company launched a drug research project called Humet with a view to treat different types of diseases with trace element products. The company s own product, HUMET-R, was introduced in 1994. | ||||||
| Listed securities of the issuer |
|
| Basic Information | |
|---|---|
| Ticker | NUTEX |
| ISIN | HU0000207634 |
| Date of listing | 25 Jul 1996 |
| Currency of trading | HUF |
| Face Value | 6 HUF |
| Number of securities listed | 171,210,766 |
| Market Capitalisation (HUF million) | 2,132 |
| > Split (S)/Reverse split (R) | |
|---|---|
| 01 Oct 2002 | R (10 : 1) |
| 03 Mar 2011 | R (4 : 1) |
| P/BV | |
|---|---|
| P/BV* | 0.3498 |
* Calculating based on the capitalisation of the actual series only
| Performance | |
|---|---|
* annualized yield
Key annual data
audited, consolidated, IFRS; Business Year: January 1 - December 31| 20241 | 20252 | |
|---|---|---|
| (thousand HUF) | (thousand HUF) | |
| Total revenues | 450 | 450 |
| Operating Profit (EBIT) | -97,130 | -112,015 |
| Net income from financial activities | 563,266 | 655,047 |
| Profit before tax | 466,136 | 543,032 |
| Profit after tax | 423,412 | 494,171 |
| Fixed Assets | 131 | 223 |
| Total liabilities | 42,421 | 35,718 |
| Share capital | 888,875 | 950,675 |
| Shareholders equity | 4,955,939 | 5,519,562 |
| Total assets | 4,998,360 | 5,555,280 |
| Number of employees (at business year end) | 1 | 2 |
- (1) audited, non-consolidated, IFRS; Business Year: January 1 - December 31
- (2) audited, consolidated, IFRS; Business Year: January 1 - December 31
Selected financial ratios
Ratios are based on data submitted by the company| 2024 | 2025 | |
|---|---|---|
| Equity Ratio | 0.01 | 0.01 |
| Return on equity (ROE) | 0.09 | 0.09 |
| Return on assets (ROA) | 0.08 | 0.09 |
Mid-year reports
non-audited, consolidated, IFRS; Business Year: January 1 - June 30| Key P&L Figures | Jan 2025 - Jun 20251 | Jan 2026 - Jun 20261 |
|---|---|---|
| (thousand HUF) | (thousand HUF) | |
| Net sales | 225 | 225 |
| Operating profit (EBIT) | -128,491 | -80,641 |
| Net income from financial activities | 258,843 | 598,522 |
| Profit before tax | 130,352 | 517,881 |
| Profit after tax | 115,417 | 517,706 |
| Key Balance Sheet Items | 30 Jun 2025 | 30 Jun 2026 |
|---|---|---|
| (thousand HUF) | (thousand HUF) | |
| Fixed Assets | 8,587 | 530 |
| Intangible Assets | 0 | 0 |
| Tangible assets | 8,587 | 530 |
| Invested financial assets | 0 | 0 |
| Current Assets | 5,195,254 | 6,103,262 |
| Inventory | 0 | 0 |
| Total assets | 5,203,841 | 6,103,792 |
| Shareholders equity | 5,187,050 | 6,094,331 |
| Share capital | 950,675 | 1,027,475 |
| Long-term liabilities | 0 | 0 |
| Short-term liabilities | 16,791 | 9,461 |
| Total liabilities and shareholders equity | 5,203,841 | 6,103,792 |
- (1) non-audited, consolidated, IFRS; Business Year: January 1 - June 30
| Shareholders exceeding 5% stake with respect to the listed series | ||
|---|---|---|
| Name | Shareholding (%) | Share piece |
| NUTEX Nyrt. MRP Szervezet | 24.01 | 41,100,000 |
| Free Float: 75.99% | Last update: 31 Aug 2026 | |
| Note: When determining the Free Float for a particular series, all the securities of the company shall be regarded to be publicly held other than (i) the stock of securities held by holders with direct holdings of more than 5% of the total number of securities, (ii) securities in the possession of custodians, provided the certificate available to the custodian verifies that the particular person holds more than 5% of the total number of securities outstanding belonging to the series. The value of the free float is based on the data provided by the issuer. | ||
| Management | |
|---|---|
| Board of Directors | CSEREKLEI Gábor Sándor, VARGHA Viola, VARGHÁNÉ BARTA Anikó, KAPROS Dóra, FILE Szabolcs |
| Management | CSEREKLEI Gábor CEO |
| Last update: 05 Jan 2023 | |
Note: Publications of this issuer are available in Hungarian only.
| Publication | News |
|---|---|
| 21 Oct 2026 23:42 | Rendkívüli tájékoztatás |
| 21 Oct 2026 23:40 | Rendkívüli tájékoztatás |
| 13 Oct 2026 23:20 | Rendkívüli tájékoztatás |
| 30 Sep 2026 20:08 | Tájékoztatás a szavazati jogok számáról |
| 30 Sep 2026 20:05 | Féléves jelentés |
| 01 Sep 2026 18:10 | Tájékoztatás a szavazati jogok számáról |
| 01 Sep 2026 18:08 | Rendkívüli tájékoztatás |
| 25 Aug 2026 22:32 | Rendkívüli tájékoztatás |
| 25 Aug 2026 22:28 | Alapszabály |
| 25 Aug 2026 22:25 | Rendkívüli tájékoztatás |
| Publication | Report |
|---|---|
| 28 Apr 2026 22:32 | Éves Jelentés |
| 30 Sep 2026 20:05 | Féléves jelentés |
| 28 Apr 2026 22:36 | Felelős Társaságirányítási Jelentés |
| Publication | Articles of Association |
|---|---|
| 25 Aug 2026 22:28 | Alapszabály |
| Publication | Voting rights, registered capital |
|---|---|
| 30 Sep 2026 20:08 | Tájékoztatás a szavazati jogok számáról |
| Name of security | NUTEX share |
| Issuer | NUTEX Investments Public Limited Company |
| Equity class | Ordinary share |
| Type of security | Registered |
| Form of security | Dematerialised |
| Code of security (ISIN) | HU0000207634 |
| Ticker symbol | NUTEX |
| Face value | 6 HUF |
| Number of securities listed | 171,210,766 |
| Rights to dividends | Full year |
| Listing date | 25 Jul 1996 |
| First Trading Day | 25 Jul 1996 |
| Market | Standard |
| Trading Unit | |
| Currency of trading | HUF |
| Trading time | |
| Listing price | 154 |